Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Sidus Space (SIDU) Stock Soars 180% on NASA News

Today, investors in SIDU stock are cheering an announced contract that provides revenue potential for Sidus Space.

Rivian Stock Warning: Could the EV Startup Really Go Bankrupt?

Today's 75 basis point interest rate hike appears to have investors in beaten-up Rivian stock looking on the bright side.

Goodbye DIDI Stock, Hello DIDIY! Ride-Hailing Giant Starts Trading on OTC Markets.

Today marks the first day of trading for DIDI under its new DIDIY stock ticker on the over the counter exchange - here's what to know.

VOO ETF: What Is Going on With the Vanguard 500 Index Fund Today?

Is now the time to buy the VOO ETF, or is a better strategy to sit on the sidelines and wait out this volatility? Let's take a closer look.

Why Is Day One Biopharmaceuticals (DAWN) Stock Up 103% Today?

Today's announcement of positive clinical trial results for a key pediatric tumor drug has DAWN stock more than doubling on Monday.

Why Are Dow Jones Stocks Down Today?

Today, the typically stable group of blue chip Dow Jones stocks are seeing incredible selling pressure as we enter a bear market.

Why Is Redbox (RDBX) Stock Up Again Today?

Today, investors in Redbox and RDBX stock are seeing the company's valuation climb to an impressive premium over its takeover price.

Cogent Biosciences (COGT) Stock Soars 90% on Positive Clinical Data

Today, investors in Cogent Biosciences and COGT stock have some promising clinical trial results to look at, as this stock soars.

AAPL, AMZN, GOOG, INTC, MSFT: Why Are Tech Stocks Down Today?

Today, investors in a rather broad basket of high-quality blue-chip tech stocks are in selling mode on the back of two key catalysts.

DIS Stock Is in Focus as Content Executive Peter Rice Departs From Disney

Today, investors in DIS stock are pricing in an announcement that a key executive in Disney's content division has been fired.